Dr Reddy's Laboratories share price fell more than 11 percent intraday on BSE after the company declared its June quarter numbers.
The company has reported consolidated profit at Rs 570.8 crore for the quarter ended June 2021, a 1.5 percent drop from the year-ago period. Profit in June 2020 quarter stood at Rs 579.3 crore.
Revenue from operations grew by 11.4 percent year-on-year to Rs 4,919.4 crore in Q1FY22.
Earnings before interest, tax, depreciation and amortization (EBITDA) was down 12.3 percent at Rs 1,019 crore against Rs 1,162.2 crore, while margin was down at 20.7 percent versus 26.3 percent, YoY.
Gross profit rose 3.8 percent year-on-year to Rs 2,569.9 crore in the quarter ended June 2021.
The pharmaceutical services and active ingredients segment reported a 12 percent year-on-year decline at Rs 754 crore during the quarter ended June 2021.
Shares of the company traded 11.09 percent lower at Rs 4,809.25 at 1430 hours.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
